Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?

Affiliations

¹ Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece. a.anastasilakis@gmail.com.
² Laboratory of Research of Musculoskeletal System "Th. Garofalidis", Medical School, KAT Hospital, University of Athens, Kifisia, Greece.
³ Laboratory of Clinical and Molecular Endocrinology, 1st Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁴ First Department of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁵ Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.

Comment

Athanasios D Anastasilakis et al. Calcif Tissue Int. 2018 Jul.

. 2018 Jul;103(1):107-108.

doi: 10.1007/s00223-018-0409-1. Epub 2018 Feb 28.

¹ Department of Endocrinology, 424 General Military Hospital, Thessaloniki, Greece. a.anastasilakis@gmail.com.
² Laboratory of Research of Musculoskeletal System "Th. Garofalidis", Medical School, KAT Hospital, University of Athens, Kifisia, Greece.
³ Laboratory of Clinical and Molecular Endocrinology, 1st Department of Internal Medicine, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁴ First Department of Pharmacology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
⁵ Department of Endocrinology and Diabetes, 251 Hellenic Air Force & VA General Hospital, Athens, Greece.

No abstract available

Comment on

Vertebral Fractures Following Denosumab Discontinuation in Patients with Prolonged Exposure to Bisphosphonates.
Tripto-Shkolnik L, Rouach V, Marcus Y, Rotman-Pikielny P, Benbassat C, Vered I. Tripto-Shkolnik L, et al. Calcif Tissue Int. 2018 Jul;103(1):44-49. doi: 10.1007/s00223-018-0389-1. Epub 2018 Feb 2. Calcif Tissue Int. 2018. PMID: 29396698